You are on page 1of 16

STUDY ABOUT THE CADILA PHARMACEUTICAL LIMITED

About Cadila Pharmaceuticals Limited Cadila Pharmaceuticals Ltd., established in 1951, is a true Life Sciences company and over the years has emerged as the undisputed leader with largest range of therapeutic groups. The company covers the entire gamut of pharmaceuticals

HISTORY

Largest privately held pharmaceutical companies in India


Headquarter at Ahmedabad PI plants located at Ankleshwar, Vadodra and Patalganga It has best Research and Development setups in India It is manned by 350 scientists and engineers

They are from various disciplines including biology, pharmacology, clinical research, chemistry, toxicology, photochemistry and different disciplines of engineering It has a multicultural, multilingual and multinational workforce of more than 4000 employee including 200 people out side Indian 49countries of Africa,CIS,Japan,USA First Indian company to get IND approval by USFDA It has four more INDs with USDFA One for pulmonary tuberculosis, rest for various type of cancer, e.g., Lung cancer, Prostrate cancer, Bladder cancer and Melanoma

MILESTONE

Best research and development set-ups in the country Host of BIOTECH product launched Worlds first manufacture of immuvac-a unique immunomodulator USFDA approvals for fluoxetine and Ethambutol manufacturing facilities Asias only manufacture of SULFOLANE(tetramethylene sulfone) Leadership in domestic marketing and distribution management

INTERNATIONAL BUSINESS

A significant presence in the Americas, CIS country, Africa, Central and South-east Asia, Oceanic countries, Japan, Middle East and Europe It has offices in USA, Japan, Kenya, Nigeria, Russia, Kazakhstan and ukrain International SBU plans to expand operations to more than 100 countries by 2010 Focus is on building brands in the following therapeutic segments: Anti-infective, Gastrointestinal, Analgesic, Respiratory, Cardiovascular, Ophthalmology, Bio-tchnical products

PRODUCT CAPACITY

MAIN PHARMA PRODOTION CAPACITY Tablets: 3900 million/year Capsules: 150 million/year Liquid: 6000 million kilolitres/year Sterile vias: 84 million/year Ampoules: 84 million/year Granules: 15.6 tones/year

BETA LACTUM /CEPHALOSPORIN Dry sterile vials: 48 million/year Dry syrup bottles: 27 million/year Capsules: 630 million/year Tablets: 510million/year

CHAMPION BRAND

ENVAS ACILOC LMX, SYMBIOTIK,CLAX RABELOC ACILOC RD, ZASO MIXULIN,MONTELAST,NODON First company in INDIA to introduce RABEPRAZOLE and FOSINPRIL formulations

PRODUCT

It caters to over 50 therapeutic areas Cardiovascular, gastrointestinal, analgesics, haematinics, anti-invectives and antibiotics, respiratory agents, antidiabetics and immunological Biotechonolgy products and digonontic kits, plants tissue culture Rabies immunoglobin and diagnostic kits for detection of HIV and HCV Companies also manufacturer tablet presses,capsule filling machine,pharma machinery parts and hospital disposables like gloves

MARKETING DIVISIONS

Magna-Practitioners, physicians, surgeons cardiologists, gastroenterologists Maxima-Chest physians, Dentists, surgeons Volta-cardiology, diabetology, nephrology, critical care Oncocare cadigran, caditrex,karplat,

THANK YOU